Keywords
weight-bearing heel - reconstruction - fasciocutaneous - musculocutaneous
Introduction
Soft tissue defects of the heel pose a challenging problem in reconstruction, due
to lack of local tissues for transfer and weight-bearing requirement of this region.[1] The thick, glabrous skin of the heel, is anchored to the deeper plantar aponeurosis
by plenty of fibrous septa traversing the subcutaneous tissue which divides the subcutaneous
fat into small loculi.[2] These loculi act as a shock absorbing system preventing shear and withstanding prolonged
weight bearing.
Although local flaps can be used for small defects, extensive defects require microsurgical
reconstruction.[1] Two types of transfers predominantly done are split-skin grafted muscle and fasciocutaneous
flaps (FCFs).[3] Muscle flaps (MFs) have better adherence to wound bed, skin-grafted muscle integrates
to form a pad which resists shearing and can provide three-dimensional coverage for
extensive defects.[4] The disadvantage is the absence of sensation which makes it prone to ulceration.
FCF are thin, pliable, and can be neurotized providing neurosensory flaps, but are
more prone to shear.[5]
Owing to the lack of high-level evidence in the previous meta-analysis conducted in
2015,[6] whether one flap is better than the other remains unclear. There is also lack of
evidence regarding sensory recovery, time to mobilize, and gait abnormalities between
the two flaps in the previous reported studies. Thus, the purpose of this study was
to perform a systematic review and meta-analysis to ascertain if there was an advantage
of one flap over the other. Furthermore, this study seeks to better understand whether
sensory recovery improved the durability of the flaps, and the role of neurosensory
flaps. Lastly, this study reviews the outcomes of time to full weight-bearing and
gait abnormalities reported on reconstructed heels.
We present our illustrative case series of patients reconstructed with MF for heel
defects. This is followed by systematic review and meta-analyses of available literature
on reconstruction of heel defects with free MF and FCF.
Case Series
Eight patients from 2017 to 2021 had undergone heel reconstruction with free MF. Patient
age ranged from 32 to 50 years and indication for reconstruction was trauma due to
road traffic accidents. Defects ranged in size from 80 to 510 cm2. The most commonly used muscle was latissimus dorsi (n = 7) followed by gracilis (n = 1). During the surgery thorough wound debridement including resection of bony spurs
was performed ([Fig. 1]). All the anastomoses were done end-to-side to the posterior tibial artery and end-to-end
to its vena comitantes. Muscle reinnervation was not attempted. During inset, the
MF was tucked for 1 cm under the overlying skin to reduce the incidence of hyperkeratosis/hypertrophy
at the skin-muscle junction. All the flaps survived requiring no anastomotic revisions
during the immediate postoperative period. The patients were maintained on external
fixators with elevating columns. After 4 weeks the elevating columns were removed
and patients were started on gradual weight bearing and full weight bearing was achieved
by 6 to 7 weeks. Custom-made supportive shoes were used in all patients. Direct observation
of gait showed that, each patient developed an individual compensatory gait pattern.
All patients had protective sensation and were aware of deep pressure sensation. Four
out of eight patients (50%) developed superficial ulcers and were managed conservatively
([Fig. 2]). Flap revisions and debulking were not required in these patients during follow-up.
Fig. 1 (A) Heel defect with exposed calcaneum and plantar fascia. (B) Latissimus dorsi muscle flap with the pedicle. (C) Artery anastomosed end-to-side with posterior tibial artery, vein anastomosed end-to-end
with venae comitantes. (D) Flap after inset.
Fig. 2 Superficial ulceration in the lateral aspect of a free latissimus dorsi muscle flap.
Materials and Methods
Protocol and Registration
This systematic review and meta-analysis were conducted with a predefined protocol
registered in PROSPERO (CRD42021250952). The Preferred Reporting Items for Systematic
Reviews and Meta-Analyses guidelines were followed.[7]
Search Strategy and Data Extraction
A systematic literature search was performed in MEDLINE/PubMed, IndMED, ScienceDirect,
and Cochrane Library using the following keywords “Muscle flap,” “free flap,” “fasciocutaneous
flap,” “heel reconstruction,” “foot,” “trauma,” and “weight bearing.” These search
terms were adapted with different bibliographic databases in combination with database-specific
filters, for example, MEDLINE/PubMed search was performed with PubMed Advanced Search
Builder using search terms entered with Boolean operator AND, OR, and AND NOT. Database
search and extraction was done from April 23, 2021 to May 1, 2021. Title and abstract
screening were done for all studies published till April 2021 by two reviewers. The
inclusion criteria were: studies reporting outcome analysis for heel reconstruction
with free MF or FCF and a minimum follow-up of 6 months. Case reports were included
if sample size is ≥ 4. Letters to the editor, conference abstracts, book chapters,
and expert reviews were all excluded. Studies reporting compound flaps were excluded.
After removal of duplicates, full texts were obtained and screened. Full-text articles
meeting our criteria were included. Reference list of included articles were screened
for additional relevant studies. Conflicts were resolved by consensus. Independent
data extraction and recording were done by two independent investigators. The following
data were extracted from the included studies: name of the first author, year of the
study, study design, sample size, etiology of the defect, mean age, gender, duration
of follow-up, type of flap used, acute revision rates, survival of the flaps, innervation,
wound healing complications, time of weight bearing, sensation, ulceration rates,
gait analysis, shear, footwear modification, and need for revision procedures.
Statistical Analysis
A kappa statistic was calculated for interreviewer agreement for study inclusion.[8] We analyzed each outcome separately and each analysis included only studies reporting
those outcomes. Risk ratios (RRs) and their corresponding 95% confidence intervals
(CIs) for comparable outcomes were measured using a fixed effect model with Mantel–Haenszel
analysis method. Some outcomes were measured with standardized mean difference using
a random effects model with an inverse-variance approach. Heterogeneity among studies
was quantified with chi-square test and I
2 statistic.[9]
I
2 > 75% represented considerable heterogeneity.[10] Subgroup analysis was performed for outcomes with considerable heterogeneity. Trial
Sequential Analysis (TSA) with monitoring boundaries was performed to overcome the
low methodological quality, outcome measure bias, publication bias, and small study
bias. Sequential monitoring boundaries were applied to meta-analysis to improve the
statistical significance of results.[11] Funnel plots were used for assessing the small study effects and reporting bias.[12] Meta-analysis was conducted with Review Manager (RevMan) [Computer program], Version
5.4, The Cochrane Collaboration, 2020.[13] TSA was performed with TSA [Computer program], Version 0.9.5.10 Beta, The Copenhagen
Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen
University Hospital – Rigs Hospitalet, 2021.[14]
Assessment of Methodological Quality
Methodological quality assessment was performed by two independent reviewers using
the Methodological Index for Non-Randomized Studies (MINORS) scale.[15] MINORS scale contains 12 items, the first 8 for noncomparative studies and additional
4 items for comparative studies. The global ideal score is 16 for noncomparative studies
and 24 for comparative studies.
Results
Study and Patient Characteristics
Of the 757 records identified, 20 articles published from 1983 to 2020 were included
([Fig. 3]). Studies included 14 prospective and 6 retrospective cohorts. Ten articles[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25] reported on FCF reconstruction, three[26]
[27]
[28] included MF, and seven[1]
[29]
[30]
[31]
[32]
[33]
[34] compared both flaps ([Table 1]). The 20 included studies encompassed 255 patients with a mean follow-up of 2.79 ± 1.52
years. Patient age ranged from 2.5 to 80 years. The majority of heel reconstructions
were performed for trauma-related indications (n = 163 [63.9%]), the remaining were done for malignancies (11%), diabetic foot ulcers
(5%), and others (18%).
Fig. 3 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart.
Table 1
Summary of study characteristics
Study
|
No. of patients
|
Fasciocutaneous flap
|
Muscle flap
|
Innervation of the flap
|
Reexploration in acute period
|
Time to ambulation
|
Gait abnormality
|
Harris et al, 1994
|
13
|
−
|
LD-13
|
No
|
2 vein revisions
|
1 month
|
No abnormality
|
Heymans et al, 2005
|
6
|
Temporal flap-6
|
−
|
No
|
1 vein revision
|
NR
|
FCF-1
|
Kuran et al, 2000
|
5
|
RF-3
|
RA-2
|
RF-3
|
NR
|
NR
|
NR
|
Langstein et al, 2002
|
9
|
RF-2 ALT-1
|
Gr-3, LD-1, RA-1, BF-1
|
No
|
2 vascular revisions
|
2.5 months
|
NR
|
Noever et al, 1986
|
4
|
RF-4
|
−
|
RF-4
|
Nil
|
NR
|
FCF-4
|
Oztürk et al, 2005
|
72
|
−
|
LD-42, RA-30
|
No
|
7 vascular revisions
|
2.5 months
|
NR
|
Potparić and Rajacić, 1997
|
15
|
RF-5,
Scapular-1
|
LD-6, RA-1, MG-2
|
RF-5, LD-2, MG-1
|
NR
|
NR
|
MF-7, FCF-2
|
Rautio et al, 1989
|
6
|
Scapular-6
|
−
|
No
|
1 artery revision
|
NR
|
NR
|
Roggero et al, 1993
|
6
|
RF-2, Lateral chest-1
|
LD-3
|
All
|
NR
|
NR
|
NR
|
Santanelli et al, 2002
|
16
|
RF-16
|
−
|
RF-9
|
Nil
|
NR
|
FCF-1
|
Weinzweig and Davies, 1998
|
8
|
RF-8
|
−
|
No
|
1 vein revision
|
NR
|
FCF-2
|
Yücel et al, 2000
|
19
|
RF-7, ALT-14
|
LD-2, Gr-8, RA-1
|
RF-7
|
NR
|
3 months
|
FCF-1, MF-1
|
Duncan et al, 1985
|
5
|
Dorsalis pedis-5
|
−
|
All
|
Nil
|
NR
|
No abnormality
|
Elgohary et al, 2018
|
25
|
RF-11, ALT-14
|
−
|
All
|
NR
|
NR
|
NR
|
El-Shazly et al, 2008
|
6
|
RF-3
|
RA-3
|
No
|
NR
|
1 month
|
NR
|
Grauberger et al, 2020
|
12
|
ALT-1
|
Gr-4, LD-6, RA-1
|
No
|
NR
|
NR
|
NR
|
Han et al, 2020
|
16
|
Medial plantar-11
|
−
|
No
|
Nil
|
NR
|
FCF-8
|
Qing et al, 2018
|
4
|
ALT-4
|
−
|
All
|
Nil
|
NR
|
NR
|
Varghese et al, 2016
|
4
|
−
|
LD-1, Gr-3
|
No
|
Nil
|
1.5 months
|
No abnormality
|
Wood et al, 1983
|
4
|
Groin-4
|
−
|
Groin-1
|
Nil
|
NR
|
NR
|
Abbreviations: ALT, anterolateral thigh; BF, biceps femoris; FCF, fasciocutaneous
flap; Gr, gracilis; LD, latissimus dorsi; MF, muscle flap; MG, medial gastrocnemius;
NR, not reported; RA, rectus abdominis; RF, radial forearm.
Surgical Characteristics
The meta-analysis included 263 flaps with 134 (50.9%) MF and 129 (49.1%) FCF. MF included
latissimus dorsi (n = 74 [55%]), rectus abdominis (29%), gracilis (13%), medial gastrocnemius (1.4%),
and biceps femoris (0.74%). Among the FCF, the most commonly done was radial forearm
flap (n = 61 [47%]), followed by anterolateral thigh flap (26%), medial plantar flap (8.5%),
scapular flap (5.4%), temporal flap (4.6%), dorsalis pedis flap (3.8%), groin flap
(3.1%), and lateral chest flap (0.77%). Among the 10 articles[17]
[19]
[21]
[22]
[24]
[25]
[29]
[31]
[32]
[33] describing neurosensory flaps, FCFs (80%) were commonly reinnervated compared with
MF (20%). Radial forearm flap innervation was done with lateral cutaneous nerve of
the forearm as donor nerve to available recipient nerves. Lateral cutaneous nerve
of thigh was used to neurotize the anterolateral thigh flap, superficial peroneal
nerve for the dorsalis pedis flap,[21] and intercostal nerves for the lateral chest flap.[32] In MF reinnervation was done either by coaptation of recipient nerve to motor nerve
of the muscle or an onlay nerve graft between the muscle and skin graft.[31]
[32]
Thirteen studies[16]
[17]
[18]
[19]
[20]
[21]
[23]
[24]
[25]
[26]
[27]
[28]
[30] report revision procedures in the immediate postoperative period. Anastomotic revisions
were higher in MF (10.5%) compared with FCF (6.3%). Regarding the survival of flaps
the meta-analysis showed an estimated RR of 1 (95% CI, 0.83, 1.21, p = 0.99) indicating no significant difference between FCF and MF ([Supplementary Fig. S1], online only). However, TSA results were inconclusive. Heterogeneity among the studies
was not important (I
2 = 0, p = 1.00).
Complications in Wound Healing
Eleven articles[1]
[16]
[17]
[21]
[22]
[24]
[26]
[27]
[30]
[33]
[34] reported on complications in wound healing in terms of infection, hematoma, partial
thickness loss, and graft loss in 5.2% of MF and 5.4% of FCF ([Table 2]). However, because of limited data regarding complications, a meta-analysis comparing
MF and FCF was not possible.
Table 2
Outcomes of included studies
Study
|
Ulceration
|
Sensation
|
Footwear modification
|
Revision procedures
|
Harris et
al, 1994
|
MF-5
|
Protective sensation present in all
|
MF-1
|
MF-1 debulking, 1 hypertrophic nodule excision and skin graft
3 excisions of the MF and replacement with lateral arm flaps
|
Heymans et al, 2005
|
FCF-1
|
Protective sensation present in all
|
FCF-1
|
FCF-1 debulking
|
Kuran et al, 2000
|
MF-2
|
MF- no sensation, FCF (innervated)- Semmes-Weinstein monofilament (SMW)- positive,
Light touch, pin prick present
|
MF-2
|
MF-1 debulking
|
Langstein et al, 2002
|
MF-1
|
NR
|
NR
|
FCF-1 debulking
|
Noever et al, 1986
|
No ulcer
|
Touch, pain, temperature in all flaps (innervated)
|
FCF-2
|
No revision procedures
|
Oztürk et al, 2005
|
MF-20
|
Protective sensation present in all
|
MF-42
|
MF-11 debulking, 9 bony prominence excision, fistulae correction-18
|
Potparić and Rajacić, 1997
|
MF-3, FCF-2
|
Protective sensation in all, touch present in FCF-5, MF-3 (innervated)
|
MF-8
|
MF-3 ulcer excisions, 2 osteomyelitis requiring bone excision, FCF-3 ulcer, 1 flap
replaced with MF due to repeated ulcerations, 2 osteomyelitis requiring bone excision
|
Rautio et al, 1989
|
FCF-4
|
NR
|
FCF-3
|
NR
|
Roggero et al, 1993
|
MF-2
|
No sensation in MF-2, protective sensation in FCF-1
|
NR
|
NR
|
Santanelli et al, 2002
|
FCF-5
|
Positive SWM test, touch, pain, temperature in all flaps
Two-point discrimination in 9 flaps (innervated)
|
FCF-1
|
No revision procedures
|
Weinzweig and Davies, 1998
|
FCF-2
|
Protective sensation present in all
|
FCF-2
|
FCF-1 debulking
|
Yücel et al, 2000
|
FCF-2, MF-1
|
Protective sensation decreased in all MF, FCF- protective sensation present
Positive SWM test present in FCF-7 (innervated)
|
FCF-2
|
FCF-2 debulking
|
Duncan et al., 1985
|
No ulcer
|
Protective sensation present in all
|
FCF-5
|
No revision procedures
|
Elgohary et al, 2018
|
FCF-3
|
Protective sensation, two-point discrimination – 20 (innervated), absent sensation-5
|
FCF-3
|
FCF-4 debulking
|
El-Shazly et al, 2008
|
No ulcer
|
Protective sensation in all groups
|
FCF-3, MF-3
|
No revision procedures
|
Grauberger et al, 2020
|
NR
|
NR
|
NR
|
NR
|
Han et al, 2020
|
No ulcer
|
Touch, pain, temperature in all flaps
|
FCF-1
|
No revision procedures
|
Qing et al, 2018
|
NR
|
SMW test positive in all cases, touch, two-point discrimination in all
|
NR
|
NR
|
Varghese et al, 2016
|
MF-1
|
NR
|
No footwear modification
|
MF-2 debulking, 1 excision of painful callosity
|
Wood et al, 1983
|
FCF-2
|
NR
|
NR
|
FCF-1 excision of hyperkeratotic lesion
|
Abbreviations: FCF, fasciocutaneous flap; MF, muscle flap; NR, not reported; SMW,
Semmes-Weinstein monofilament.
Time to Full Weight Bearing
Time to weight bear on the reconstructed heels varied from 4 weeks to 3 months.[1]
[26]
[27]
[28]
[30]
[33] Standardized mean difference with inverse-variance approach was –3.03 (95% CI, –4.25,
–1.80, p < 0.00001) suggesting that time to bear weight and subsequent return to daily activities
were earlier with FCF compared with MF ([Supplementary Fig. S2], online only). The p-value was 0.19 indicating moderate (I
2 = 41%) interstudy heterogeneity. Though only two studies compared the time to full
weight bearing, TSA Z curve crossed the conventional test boundaries with both studies reinforcing the
results of meta-analysis.
Gait Abnormality
Information on gait assessment was available in 101 flaps in 10 studies[16]
[17]
[19]
[20]
[21]
[23]
[26]
[27]
[31]
[33] but comparison was reported only in two studies.[31]
[33] Assessment was done either by observing the gait or using patients' description.
The gait pattern analyzed by two studies[29]
[33] with dynamic pedogram indicated reduced contact area of the reconstructed foot relative
to the healthy foot. However, during walking, the reconstructed area was weight bearing
and the pressure recorded was not less than the normal foot. The calculated RR was
0.55 (95% CI, 0.19, 1.59, p = 0.27) suggesting no significant difference in gait abnormalities between FCF and
MF. TSA results were inconclusive for this outcome ([Supplementary Fig. S3], online only). Interstudy heterogeneity was not important (I
2 = 0%, p = 0.27).
Sensation
Sensory assessment was reported in five studies.[1]
[29]
[31]
[32]
[33] Meta-analysis (RR of 1.99 [95% CI, 1.32, 3.00, p = 0.001]) and TSA Z curve indicated that heels reconstructed with FCF developed superior protective sensation
compared with MF ([Supplementary Fig. S4], online only). There was substantial heterogeneity among the studies (I
2 = 90%, p < 0.00001) due to inclusion of different study populations. Subgroup analysis could
not be performed due to nonavailability of data regarding the individual participant
types. There was superior perception of light touch and pain by patients who underwent
FCF reconstruction (RR, 5.17, 95% CI, 2.02, 13.22, p = 0.00006). TSA Z curve confirmed the findings ([Supplementary Fig. S5], online only). Interstudy heterogeneity was moderate (I
2 =34%, p = 0.22).
Ulceration
Six studies[1]
[29]
[30]
[31]
[32]
[33] assessed the incidence of ulceration on reconstructed heels. Though, a fixed effects
meta-analysis model yielded no significant difference in the rates of ulceration (RR,
0.65, 95% CI, 0.27, 1.54, p = 0.33) between FCF and MF, TSA graph was inconclusive ([Supplementary Fig. S6], online only). Interstudy heterogeneity was not important (I
2 = 0%, p = 0.42).
Footwear Modification
Four studies[1]
[29]
[31]
[33] reported on footwear modification. Comparing the need for footwear modification
on reconstructed heels ([Supplementary Fig. S7], online only), no significant difference was observed between the two flaps in the
meta-analysis (RR of 0.52 [95% CI, 0.26, 1.09, p = 0.09]) and TSA. There was substantial interstudy heterogeneity (I
2 = 73%, p = 0.01).
Revision Procedures
Debulking (68.7%) was the commonly reported procedure among the five studies[1]
[29]
[30]
[31]
[33] reporting revisions following reconstruction. The estimated RR of 1.67 (95% CI,
0.84, 3.32, p = 0.38) and TSA Z curve indicated no significant difference in the rates of revision procedures between
MF and FCF ([Supplementary Fig. S8], online only). The p-value of chi-squared test was 0.38 (I
2 = 2%) suggesting interstudy heterogeneity was not important.
Shear
Three articles[16]
[17]
[18] described the mobility of tissues across tangential shear forces on the reconstructed
heels. Heymans et al reported that temporal FCFs were able to resist shear owing to
their architectural similarity to the heel. Shear was measured by Noever et al by
hooking a 100-g weight to the center of the flap and measuring the yield in vertical
position. The range of shifting was from 1 to 1.7 cm. Rautio et al postulated that
shear resistance was not associated with the stability of the reconstruction. Laxity
of the scapular flaps did not correlate with the size and thickness of the flap.
Funnel plot showed symmetry suggesting the absence of publication bias and small study
effects ([Supplementary Fig. S9], online only).
Methodological Quality
The mean MINORS score was 11/16 (range: 10–12) and 15/24 (range: 14–16) for comparative
and noncomparative studies, respectively, suggesting the studies were of low methodological
quality ([Supplementary Material 1] and [2], online only). Concordance between the reviewers' assessment was excellent with
intraclass correlation 0.80 (95% CI).
Discussion
This meta-analysis showed no statistically significant difference between the two
flaps in terms of survival, gait abnormalities, rates of ulceration, need for specialized
footwears, and requirement of subsequent revision procedures. Patients reconstructed
with FCF had superior perception of deep pressure, light touch, and pain compared
with MF. Moreover, time to full weight-bearing walking following reconstruction was
longer in MF compared with FCF. TSA confirmed the findings of meta-analysis for all
the outcomes except for survival of flaps, gait assessment, and rates of ulceration.
In these outcomes, TSA was inconclusive suggesting that further information is required
before any firm conclusion can be reached.
Higher rates of vascular revisions were observed in MF in the immediate postoperative
period. One study[28] in our analysis which described MF (n = 72, 53%) for severe land mine injuries reported the highest number of vascular
revisions (9.7%). Land mine injuries generally result in composite tissue defects
with extensive soft tissue damage which might account for the higher rates of vascular
emergencies in MF. Common causes for delay in wound healing among MF were loss of
skin grafts requiring regrafting[26]
[34] and infection leading to partial loss of the muscle,[33] whereas hematoma,[33] infection,[17] and partial thickness loss[21]
[22] led to delay in FCF.
Patients who underwent heel reconstruction with MF took longer to begin full weight
bearing compared with FCF. Among the two studies included for analyzing the time to
ambulate, Kuran et al[29] compared sensate and nonsensate flaps for reconstruction of the heel. Neurosensory
radial forearm flaps were used in one group and the comparative group included noninnervated
MFs. The defects in the sensate group were slightly smaller than those in the nonsensate
group. In Langstein et al[30] the mean defect size was 63.4 cm2 for MF and 38 cm2 for FCF. Larger defects with longer healing times might contribute to the delay in
weight-bearing in heels reconstructed with MF.
Assessment of gait[31]
[33] was based on single surgeon's subjective observation as the patient walked bare
foot and with his footwear. Potparić and Rajacić devised a scale of “normal,” “acceptable,”
and “poor” considering ambulatory distance, stair climbing, ability to run, recreational
activity, and use of ancillary support. Our analysis was unable to distinguish the
role of reconstruction on gait suggesting more data are required before a firm conclusion
can be reached. This view was supported by previous investigators who reported that
gait was more dependent on the functional and anatomical status of the foot rather
than the soft tissue replacement.[35]
[36] Perttunen et al[37] proposed that patients with free flap reconstruction of the sole, reduced loading
on their flaps by altering their weight-bearing patterns. Gait patterns were modified
by patients to shorten the time spent over the reconstructed foot.
Although it would seem that heel reconstruction would require a sensate flap to avoid
recurrent breakdowns, literature is unclear on this point. Though neurosensory FCF
provide better sensory perception, the final results were not superior to MF, as indicated
by many authors.[29]
[31]
[33]
[38] On the contrary, Roggero et al[32] with a small cohort, favored neurosensory FCF stating that patients with nonsensate
flaps had higher incidence of cutaneous breakdown compared with sensate flaps. Some
authors reinnervated MFs by coaptation of motor to sensory nerve or onlay nerve grafting.[31]
[39] Although improved sensation was achieved in these flaps, the overall results were
not better than noninnervated MF. Our review and meta-analysis concurred with previous
reports[20]
[31]
[38]
[40] that some form of protective sensation is sufficient to provide durable flaps, and
FCF irrespective of their innervation status had superior protective sensation compared
with MF. On the other hand, innervated FCF may be relevant in selected cases like
incomplete spinal cord injury, where transfer of some residual innervation outside
the heel, if possible, can restore deep pressure sensation and provide durable flaps.
Several studies[40]
[41]
[42] highlighted the fact that ulceration is not correlated with the type of reconstruction,
flap sensibility, and the cause of the primary defect. Our results were inconclusive
in this regard suggesting more data are required for further analysis. Ulcerations,
however, are mechanical in origin and arise from either exogenous or endogenous causes.
Flaps that are thick and conform poorly to the underlying osseous architecture are
prone to exogenous ulcers. Hence, there is a need for flap tailoring before inset.
Ulcers from endogenous origin arise in conjunction with weight-bearing points and
pressure areas overlying osseous deformities. These high pressure sites are the most
common reason for recurrent ulcerations which can be prevented by paying attention
to the skeletal architecture during reconstruction.[40] It is important not only to resect the bony spurs and perform appropriate orthopaedic
procedures but also to provide supportive footwear for better gait and prevention
of recurrent breakdowns.
Although 70% of patients required footwear modification in our review, the meta-analysis
showed no difference in this aspect between the two flaps. Custom-made footwear has
been advocated to provide additional padding, reduce shear, and to shift weight to
a more stable area. Use of silicon insoles to reduce peak vertical pressure forces
and pressure-gait analysis to design footwear accordingly have been suggested by the
previous authors.[38]
[43]
The meta-analysis comparing the rates of revision showed no statistically significant
difference between the two flaps similar to results from previous investigators.[6] This review suggests that nature of the recipient bed and flap inset are major contributors
to the need for later revisions, rather than factors inherent to the reconstruction
itself. Adequate restoration of the skeletal components by means of bone grafts, selective
osteotomies, and/or fusions should be undertaken before soft tissue reconstruction.[31] Flap contouring before inset can reduce the shear and subsequent revisions.
Although shear was addressed in two studies,[17]
[18] the impact of shear on ambulation was not reported. Authors described their methods
of measuring shear by using weights and ultrasound. Rautio et al measured the resistance
to shear of the scapular flap and postulated that resistance was not related to the
soft tissue stability of the reconstruction. Further, thinning and tightening of the
scapular flap did not reduce the flap laxity in their study.
Shear plays an important role in the development of postoperative ulcerations, hyperkeratosis,
and hypertrophic scar formation[16] on the reconstructed heels. The thick skin of the plantar region and the underlying
subcutaneous fat allow the dispersion of shearing forces that accompany walking. Once
reconstructed with the transferred flaps, this dispersion component is lost resulting
in sliding of the foot on the flap while the patient walks. Unlike the heel skin,
the transferred free flaps are not strongly attached to the underlying calcaneum.
Skin-grafted muscle can develop two independent mobile tissue planes—one at the muscle-skin
graft interface and a second at the muscle-wound bed interface. However, with time
MF attach more strongly to the underlying bone thereby obliterating the muscle-wound
bed shear. To achieve a similar effect, theoretically, the fascia in FCF can be anchored
to the underlying periosteum to reduce shear. But the subcutaneous tissue between
the fascia and skin may contribute to shear leading to instability with ambulation.
Though the architecture of the FCF resembles more the subcutaneous elastic architecture
of the plantar skin, they are often too bulky and are difficult to attach to the underlying
periosteum.[16] MFs are advantageous in this aspect since they “stick” well and their bulk reduces
overtime with atrophy resulting in a stable construct which can withstand shear. The
impact of shear remains less understood though it is described as a key justification
in choosing MF over FCF. Further studies with adequate comparison groups are warranted
to evaluate the role of shear in the soft tissue stability of the different free flaps
used for reconstruction.
This meta-analysis is not without its limitations. Even though systematic literature
search was performed, it is possible that not all relevant studies were captured,
such as those not searchable on the included databases. This review does not exclude
the temporal bias due to the recent trends of compound flaps used for heel reconstruction.
Several studies could not be included in our analysis because they did not specify
the weight-bearing area and described reconstruction of the entire sole. There was
no consensus of the defect size with some included studies describing small defects
exclusively, and several authors chose MF for extensive defects. Etiology of the defects
were variable with some etiologies altering the osseous architecture like land mine
injuries while others preserved the skeletal elements like cutaneous malignancies,
leading to comparison of heterogeneous groups. Randomized control trials with adequate
comparison groups should be conducted comparing both the flaps standardizing the defect
size and etiology to further investigate the advantage of one flap over the other.
Conclusion
Patients reconstructed with FCF had superior sensory perception and early weight bearing
on their reconstructed heels, hence faster return to daily activities compared with
MF. In terms of other outcomes like footwear modifications and revision procedures
both flaps had no statistically significant difference. Regarding survival of flaps,
gait assessment, and rates of ulceration, the results were inconclusive suggesting
that further information is required before any firm conclusion can be reached. Although
FCF had superior sensory perception there was no improvement in durability compared
with MF. Flap reinnervation by direct nerve coaptation is worthwhile in selected patients.
Further biomechanical studies are required to investigate the role of shear on the
stability of the reconstructed heels.